The Human Medicines (Amendments Relating to Coronavirus and Influenza) (England and Wales and Scotland) Regulations 2024
These Regulations amend the Human Medicines Regulations 2012 (“the 2012 Regulations”), which govern the arrangements across the United Kingdom for the licensing, manufacture, wholesale dealing and sale or supply of medicines for human use. These Regulations extend to England and Wales and Scotland only.
Lifecycle
Department
Made
06 Mar 2024
—
In force
31 Mar 2024
Enabling power
The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 2(1), 3(1)(a) to (d), (h), (j) and (n) and (2)(a) and (c), 6(1)(b) and 43(2) of the Medicines and Medical Devices Act 2021. The Secretary of State has carried out a public consultation in accordance with section 45(1) of that Act. In accordance with section 2(2) to (4) of that Act, the Secretary of State’s overarching objective in making these Regulations is safeguarding public health, the Secretary of State has had regard to the matters specified in section 2(3) of that Act and considers that, where these Regulations may have an impact on the safety of human medicines, the benefits of making these Regulations outweigh the risks. In accordance with section 47(3) and (6)(a) of that Act, a draft of these Regulations has been laid before Parliament and approved by a resolution of each House of Parliament.
DocumentsOpen on legislation.gov.uk →